Search research articles
Contact Us
Filters
Showing results (151-160 of 224) with videos related to
Page
of 23
Sort By:
Journal of Clinical Medicine
|
March 25, 2022
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
Abed Agbarya, Walid Shalata, Alfredo Addeo, et al.
The Oncologist
|
July 29, 2022
International Survey on Frailty Assessment in Patients with Cancer
Giuseppe Luigi Banna, Ornella Cantale, Maria Monica Haydock, et al.
JCO Oncology Practice
|
February 13, 2020
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
Vittorio Fusco, Daniele Santini, Giuseppina Campisi, et al.
Current Oncology Reports
|
October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.
Cancer Biology & Therapy
|
February 3, 2005
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response
Anna Carbone, Ulrich Rodeck, Francesco Angelo Mauri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2025
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)
Alfredo Addeo, Daniel Dietrich, Nicolas Mach, et al.
Frontiers in Oncology
|
September 25, 2020
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
Christian Britschgi, Alfredo Addeo, Markus Rechsteiner, et al.
Cancer Treatment Reviews
|
January 3, 2026
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?
Seng Wee Cheo, Molly S C Li, Derek De-Rui Huang, et al.
Cancer Treatment Reviews
|
February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Translational Lung Cancer Research
|
September 12, 2022
Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Dongliang Bian, Siming Jiang, Yicheng Xiong, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 224) with videos related to
Sort By:
Page
of 23
Journal of Clinical Medicine
|
March 25, 2022
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
Abed Agbarya, Walid Shalata, Alfredo Addeo, et al.
The Oncologist
|
July 29, 2022
International Survey on Frailty Assessment in Patients with Cancer
Giuseppe Luigi Banna, Ornella Cantale, Maria Monica Haydock, et al.
JCO Oncology Practice
|
February 13, 2020
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
Vittorio Fusco, Daniele Santini, Giuseppina Campisi, et al.
Current Oncology Reports
|
October 18, 2022
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, et al.
Cancer Biology & Therapy
|
February 3, 2005
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response
Anna Carbone, Ulrich Rodeck, Francesco Angelo Mauri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2025
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)
Alfredo Addeo, Daniel Dietrich, Nicolas Mach, et al.
Frontiers in Oncology
|
September 25, 2020
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
Christian Britschgi, Alfredo Addeo, Markus Rechsteiner, et al.
Cancer Treatment Reviews
|
January 3, 2026
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?
Seng Wee Cheo, Molly S C Li, Derek De-Rui Huang, et al.
Cancer Treatment Reviews
|
February 20, 2025
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P L Saw, Lizza Hendriks, et al.
Translational Lung Cancer Research
|
September 12, 2022
Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Dongliang Bian, Siming Jiang, Yicheng Xiong, et al.
Page
of 23